Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”

Jun Fukihara; Koji Sakamoto; Junji Koyama; Takayasu Ito; Shingo Iwano; Masahiro Morise; Masahiro Ogawa; Yasuhiro Kondoh; Tomoki Kimura; Naozumi Hashimoto; Yoshinori Hasegawa

doi:10.1016/j.cllc.2019.11.013

Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”

Jun Fukihara, Koji Sakamoto, Junji Koyama, Takayasu Ito, Shingo Iwano, Masahiro Morise, Masahiro Ogawa, Yasuhiro Kondoh, Tomoki Kimura, Naozumi Hashimoto, Yoshinori Hasegawa

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	e205
Journal	Clinical Lung Cancer
Volume	21
Issue number	3
DOIs	https://doi.org/10.1016/j.cllc.2019.11.013
Publication status	Published - 05-2020
Externally published	Yes

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cllc.2019.11.013

Cite this

Fukihara, J., Sakamoto, K., Koyama, J., Ito, T., Iwano, S., Morise, M., Ogawa, M., Kondoh, Y., Kimura, T., Hashimoto, N., & Hasegawa, Y. (2020). Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”. Clinical Lung Cancer, 21(3), e205. https://doi.org/10.1016/j.cllc.2019.11.013

@article{54039a66d37948de91ad996ccd7a3002,

title = "Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”",

author = "Jun Fukihara and Koji Sakamoto and Junji Koyama and Takayasu Ito and Shingo Iwano and Masahiro Morise and Masahiro Ogawa and Yasuhiro Kondoh and Tomoki Kimura and Naozumi Hashimoto and Yoshinori Hasegawa",

year = "2020",

month = may,

doi = "10.1016/j.cllc.2019.11.013",

language = "English",

volume = "21",

pages = "e205",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "3",

}

Fukihara, J, Sakamoto, K, Koyama, J, Ito, T, Iwano, S, Morise, M, Ogawa, M, Kondoh, Y, Kimura, T, Hashimoto, N & Hasegawa, Y 2020, 'Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”', Clinical Lung Cancer, vol. 21, no. 3, pp. e205. https://doi.org/10.1016/j.cllc.2019.11.013

TY - JOUR

T1 - Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”

AU - Fukihara, Jun

AU - Sakamoto, Koji

AU - Koyama, Junji

AU - Ito, Takayasu

AU - Iwano, Shingo

AU - Morise, Masahiro

AU - Ogawa, Masahiro

AU - Kondoh, Yasuhiro

AU - Kimura, Tomoki

AU - Hashimoto, Naozumi

AU - Hasegawa, Yoshinori

PY - 2020/5

Y1 - 2020/5

UR - http://www.scopus.com/inward/record.url?scp=85083484037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083484037&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2019.11.013

DO - 10.1016/j.cllc.2019.11.013

M3 - Letter

C2 - 31874731

AN - SCOPUS:85083484037

SN - 1525-7304

VL - 21

SP - e205

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 3

ER -

Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this